Kolon TissueGene, Inc. (KOSDAQ: 950160)

South Korea flag South Korea · Delayed Price · Currency is KRW
22,900
-1,400 (-5.76%)
Dec 19, 2024, 2:50 PM KST
171.65%
Market Cap 1.85T
Revenue n/a
Net Income n/a
Shares Out 79.47M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 759,839
Open 23,100
Previous Close 24,300
Day's Range 22,600 - 25,450
52-Week Range 8,240 - 28,600
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About Kolon TissueGene

Kolon TissueGene, Inc. develops cell therapies to target various orthopedic diseases and degenerative disorders. The company is developing cell therapies for osteoarthritis and musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Employees 29
Stock Exchange KOSDAQ
Ticker Symbol 950160
Full Company Profile

News

There is no news available yet.